acetylcarnitine and (5-(3-thienyl)tetrazol-1-yl)acetic acid

acetylcarnitine has been researched along with (5-(3-thienyl)tetrazol-1-yl)acetic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaya, S; Hamada, Y; Hara, T; Hotta, N; Kasuya, Y; Kato, K; Koh, N; Komori, T; Nakamura, J; Nakashima, E; Naruse, K; Sakakibara, F; Sasaki, H; Takeuchi, N1

Other Studies

1 other study(ies) available for acetylcarnitine and (5-(3-thienyl)tetrazol-1-yl)acetic acid

ArticleYear
Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:3

    Topics: Acetylcarnitine; Aldehyde Reductase; Animals; Body Weight; Carnitine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Inhibitors; Hemodynamics; Male; Neural Conduction; Polymers; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Tetrazoles; Thiophenes

1998